Circulation最新文献

筛选
英文 中文
Correlation Between EMS Agency Rates of Survival to Hospital Admission and Hospital Survival Outcomes for Cardiac Arrest. EMS机构对心脏骤停的住院存活率与医院生存结果的相关性
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-27 Epub Date: 2026-09-01 DOI: 10.1161/CIRCULATIONAHA.126.079735
Tanawat Attachaipanich, Saket Girotra, Kevin F Kennedy, Bryan F McNally, Paul S Chan
{"title":"Correlation Between EMS Agency Rates of Survival to Hospital Admission and Hospital Survival Outcomes for Cardiac Arrest.","authors":"Tanawat Attachaipanich, Saket Girotra, Kevin F Kennedy, Bryan F McNally, Paul S Chan","doi":"10.1161/CIRCULATIONAHA.126.079735","DOIUrl":"10.1161/CIRCULATIONAHA.126.079735","url":null,"abstract":"<p><strong>Background: </strong>Survival to hospital admission for out-of-hospital cardiac arrest is an important resuscitation outcome to gauge emergency medical service (EMS) agency performance. However, its correlation with EMS rates of survival to hospital discharge and favorable neurological survival is unclear.</p><p><strong>Methods: </strong>Using the Cardiac Arrest Registry to Enhance Survival (CARES), we identified adults with nontraumatic out-of-hospital cardiac arrests during 2 periods: 2015 through 2019 (before the COVID-19 pandemic) and 2022 through 2024 (after the peak pandemic years). Multivariable hierarchical logistic regression was used to derive EMS agency-level risk-standardized survival rates for hospital admission, hospital discharge, and favorable neurological survival during each period. We then assessed the correlation between EMS agency rates of survival to admission versus discharge and favorable neurological survival using weighted linear regression, and whether the correlations differed by neighborhood income (above versus below median household income) and race and ethnicity (categorized as predominantly White [>80% of residents], majority Black or Hispanic [>50% of residents], or integrated).</p><p><strong>Results: </strong>A total of 544 296 events from 1838 EMS agencies met inclusion criteria (252 137 pre-COVID; 292 159 post-COVID). During the period of 2015 to 2019, EMS rates of survival to admission were strongly correlated with survival to discharge (weighted <i>r</i>=0.68 [95% CI, 0.64-0.72]) and favorable neurological survival (weighted <i>r</i>=0.54 [95% CI, 0.43-0.59]). These correlations were similar during the period of 2022 through 2024 (weighted <i>r</i>=0.63 [95% CI, 0.59-0.66] and weighted <i>r</i>=0.48 [95% CI, 0.44-0.53], respectively). Neighborhood racial and ethnic composition modified the correlation between EMS rates of survival to admission and survival outcomes at discharge in both periods (all interactions <0.05), but the correlations remained strong in each neighborhood group. Similar findings were found for the interactions by neighborhood income strata.</p><p><strong>Conclusions: </strong>EMS agency rates of survival to hospital admission are strongly correlated with their rates of survival to hospital discharge and favorable neurological survival. These findings support the use of survival to hospital admission as a performance metric for EMS systems.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":"1692-1699"},"PeriodicalIF":41.3,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13536967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ROR2 Drives Right Ventricular Heart Failure Through Disruption of Proteostasis. ROR2通过破坏蛋白质平衡导致右心室心力衰竭。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.125.078798
Hali Hartman, Genevieve Uy, Keita Uchida, Emily A Scarborough, Yifan Yang, Eric W Barr, Spencer Williams, Ryan T Santilli, Sanam L Kavari, Jeff Brandimarto, Li Li, Ling Lai, Joanna Griffin, Nora Yucel, Swapnil Shewale, Hari Rajagopal, Deborah M Eaton, Tanis Dorwart, Kenneth C Bedi, Crystal S Conn, Kenneth B Margulies, Benjamin L Prosser, Zoltan Arany, Jonathan J Edwards
{"title":"ROR2 Drives Right Ventricular Heart Failure Through Disruption of Proteostasis.","authors":"Hali Hartman, Genevieve Uy, Keita Uchida, Emily A Scarborough, Yifan Yang, Eric W Barr, Spencer Williams, Ryan T Santilli, Sanam L Kavari, Jeff Brandimarto, Li Li, Ling Lai, Joanna Griffin, Nora Yucel, Swapnil Shewale, Hari Rajagopal, Deborah M Eaton, Tanis Dorwart, Kenneth C Bedi, Crystal S Conn, Kenneth B Margulies, Benjamin L Prosser, Zoltan Arany, Jonathan J Edwards","doi":"10.1161/CIRCULATIONAHA.125.078798","DOIUrl":"10.1161/CIRCULATIONAHA.125.078798","url":null,"abstract":"<p><strong>Background: </strong>No therapies exist to reverse right ventricular failure (RVF), and the molecular mechanisms that drive RVF remain understudied. We recently reported that the developmentally restricted noncanonical WNT receptor <i>ROR2</i> (receptor tyrosine kinase-like orphan receptor 2) is upregulated in human RVF in proportion to severity of disease. Here we test the mechanistic role of ROR2 in RVF pathogenesis.</p><p><strong>Methods: </strong>ROR2 was overexpressed or knocked down in neonatal rat ventricular myocytes and then characterized using confocal microscopy, RNA sequencing, proteomics, proteostatic functional assays, and pacing to assess contractile properties. The impact of cardiac ROR2 expression was evaluated in mice by AAV9-mediated overexpression and by AAV9-mediated delivery of short hairpin RNA to knockdown <i>ROR2</i> in a pulmonary artery banded pressure overload model of RVF. <i>ROR2</i>-modified mice were evaluated by echocardiography, histology, and right ventricle protein synthesis and proteasome capacity.</p><p><strong>Results: </strong>In neonatal rat ventricular myocytes, we find that ROR2 profoundly dysregulates the coordination between protein translation and folding. This imbalance leads to excess protein clearance by the ubiquitin proteasome system with dramatic impacts on sarcomere and cytoskeletal structure and function. Inhibiting the ubiquitin proteasome system or restoring chaperone expression is sufficient to partially rescue ROR2-induced structural and contractile deficits in cardiomyocytes. In mice, forced cardiac ROR2 expression is sufficient to disrupt proteostasis and drive RVF, whereas conversely <i>Ror2</i> knockdown partially rescues proteostasis and right ventricle structure and function in a pressure overload model of RVF.</p><p><strong>Conclusions: </strong>In sum, ROR2 is a key driver of RVF pathogenesis through proteostatic disruption and thus provides a promising target to treat RVF.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13718689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Women's Cardiovascular Health: From Recognition to Action. 妇女心血管健康:从认识到行动。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.126.083237
Maria A Pabon, Michael C Honigberg
{"title":"Women's Cardiovascular Health: From Recognition to Action.","authors":"Maria A Pabon, Michael C Honigberg","doi":"10.1161/CIRCULATIONAHA.126.083237","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.083237","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Centers of Excellence for Women's Cardiovascular Care: A Science Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. 妇女心血管护理综合卓越中心:来自美国心脏协会、美国儿科学会、美国妇产科医师学会和母胎医学学会的科学咨询。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIR.0000000000001481
Natalie A Cameron, Sadiya S Khan, C Noel Bairey Merz, LaPrincess C Brewer, Matthew M Davis, Erin P Ferranti, William A Grobman, Afshan B Hameed, Tamara S Hannon, Robert A Harrington, Heather M Johnson, Mary E Maradik, Amanda M Perak, Harmony R Reynolds, Stacey E Rosen, Monika Sanghavi, Jennifer Schulte, Radhika Rajgopal Singh, Madeline R Sterling, Rachel G Tabak, Nisha Verma, Ashley E Weedn, Malissa J Wood, Esther S H Kim
{"title":"Comprehensive Centers of Excellence for Women's Cardiovascular Care: A Science Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine.","authors":"Natalie A Cameron, Sadiya S Khan, C Noel Bairey Merz, LaPrincess C Brewer, Matthew M Davis, Erin P Ferranti, William A Grobman, Afshan B Hameed, Tamara S Hannon, Robert A Harrington, Heather M Johnson, Mary E Maradik, Amanda M Perak, Harmony R Reynolds, Stacey E Rosen, Monika Sanghavi, Jennifer Schulte, Radhika Rajgopal Singh, Madeline R Sterling, Rachel G Tabak, Nisha Verma, Ashley E Weedn, Malissa J Wood, Esther S H Kim","doi":"10.1161/CIR.0000000000001481","DOIUrl":"https://doi.org/10.1161/CIR.0000000000001481","url":null,"abstract":"<p><p>Improving cardiovascular health in women is an urgent public health priority given the persistent and pervasive gaps in awareness, prevention, and management of cardiovascular disease in this population. Advances in scientific understanding have led to increased recognition of female-specific considerations in cardiovascular disease, which informed the development of the Female Life Stage construct by the American Heart Association in collaboration with the American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. This construct integrates assessment of hormonal, psychosocial, and cardiovascular health across life stages. However, gaps remain in operationalizing this construct and optimizing the delivery of patient-centered, interdisciplinary care among women. Over the past several decades, women's cardiovascular centers have emerged as leaders, expanded rapidly, and elevated the recognition of cardiovascular diseases that exclusively, disproportionately, or differently affect women (eg, myocardial infarction with nonobstructive coronary arteries, spontaneous coronary artery dissection, Takotsubo syndrome). In this science advisory, we describe the current landscape of women's cardiovascular centers and propose a national infrastructure to support the expansion of dedicated Comprehensive Centers of Excellence for Women's Cardiovascular Care. These centers are conceptualized as interdisciplinary care models comprising 4 defining pillars: interdisciplinary clinical care, education and training, research, and community engagement. By establishing integrated pathways that span clinical disciplines, these centers can reduce fragmentation, enhance earlier risk identification, and expand opportunities to increase representation of women in clinical research. In doing so, they offer a bold opportunity for a scalable and equitable model to improve cardiovascular health for all women.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. 女性心血管疾病预防和管理共识指南:来自美国心脏协会、美国儿科学会、美国妇产科医师学会和母胎医学学会的科学声明。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIR.0000000000001482
Sadiya S Khan, William A Grobman, Sonia Angell, Linda Brubaker, Natalie A Cameron, Sarah de Ferranti, Samar R El Khoudary, Erin P Ferranti, Afshan B Hameed, Heather M Johnson, Sarah Kennedy, Esther S H Kim, Tamara S Hannon, Mary E Maradik, Karlyn A Martin, Eliza C Miller, Radhika Rajgopal Singh, Stacey E Rosen, Susan D Reed, Rachel G Tabak, S Darius Tandon, Rebecca C Thurston, Ashley E Weedn, Nisha Verma, Amanda M Perak
{"title":"Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine.","authors":"Sadiya S Khan, William A Grobman, Sonia Angell, Linda Brubaker, Natalie A Cameron, Sarah de Ferranti, Samar R El Khoudary, Erin P Ferranti, Afshan B Hameed, Heather M Johnson, Sarah Kennedy, Esther S H Kim, Tamara S Hannon, Mary E Maradik, Karlyn A Martin, Eliza C Miller, Radhika Rajgopal Singh, Stacey E Rosen, Susan D Reed, Rachel G Tabak, S Darius Tandon, Rebecca C Thurston, Ashley E Weedn, Nisha Verma, Amanda M Perak","doi":"10.1161/CIR.0000000000001482","DOIUrl":"https://doi.org/10.1161/CIR.0000000000001482","url":null,"abstract":"<p><p>There is growing recognition that the optimal prevention and management of cardiovascular disease in girls and women requires attention to sex-specific considerations relevant to the interconnected domains of hormonal, psychosocial, and cardiovascular health across the life course. Dysregulation in these health domains tends to co-occur and is associated with increased risk of cardiovascular disease. However, healthcare for girls and women is uniquely fragmented across clinical specialties, including pediatrics, adolescent medicine, primary care, obstetrics, maternal-fetal medicine, gynecology, cardiology, endocrinology, hematology, and neurology. Furthermore, inconsistent alignment across society guidelines contributes to missed opportunities to optimize cardiovascular health. Therefore, the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine convened a multisociety science advisory group and developed the Female Life Stage construct. This construct defines 4 distinct and clinically meaningful stages-perimenarche (S1), ovarian cycling (S2), perimenopause (S3), and postmenopause (S4)-to enable female-specific screening, prevention, and treatment considerations. In addition, this construct incorporates pregnancy as a unique modifying life event when cardiovascular risk may emerge or be unmasked (eg, adverse pregnancy outcomes). This scientific statement crosswalks major society guidelines, synthesizes the evidence, and provides consensus-based clinical guidance for each Female Life Stage and interconnected health domain (ie, hormonal, psychosocial, and cardiovascular health). We conclude with a call to action to improve clinical workflows, enhance clinician education, and address scientific and implementation gaps to improve cardiovascular health in girls and women.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promises to Keep: Closing the Gaps in Women's Cardiovascular Health. 信守承诺:缩小女性心血管健康的差距。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.126.083230
Gina Lundberg, Garima Sharma, Laxmi S Mehta, Annabelle S Volgman
{"title":"Promises to Keep: Closing the Gaps in Women's Cardiovascular Health.","authors":"Gina Lundberg, Garima Sharma, Laxmi S Mehta, Annabelle S Volgman","doi":"10.1161/CIRCULATIONAHA.126.083230","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.083230","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mainstreaming Cardiovascular Care for Women: From Special Population to Standard Practice. 女性心血管护理主流化:从特殊人群到标准实践。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.126.083236
Tracy Y Wang
{"title":"Mainstreaming Cardiovascular Care for Women: From Special Population to Standard Practice.","authors":"Tracy Y Wang","doi":"10.1161/CIRCULATIONAHA.126.083236","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.083236","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease: A Presidential Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. 预防和管理心血管疾病的女性特定生命过程方法:来自美国心脏协会、美国儿科学会、美国妇产科医师学会和母胎医学学会的总统咨询。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIR.0000000000001483
Sadiya S Khan, William A Grobman, Amanda M Perak, Sonia Angell, Linda Brubaker, Natalie A Cameron, Sarah de Ferranti, Samar R El Khoudary, Erin P Ferranti, Afshan B Hameed, Tamara S Hannon, Heather M Johnson, Sarah Kennedy, Esther S H Kim, Mary E Maradik, Karlyn A Martin, Eliza C Miller, Susan D Reed, Rachel G Tabak, S Darius Tandon, Rebecca C Thurston, Nisha Verma, Ashley E Weedn, Radhika Rajgopal Singh, Stacey E Rosen
{"title":"A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease: A Presidential Advisory From the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine.","authors":"Sadiya S Khan, William A Grobman, Amanda M Perak, Sonia Angell, Linda Brubaker, Natalie A Cameron, Sarah de Ferranti, Samar R El Khoudary, Erin P Ferranti, Afshan B Hameed, Tamara S Hannon, Heather M Johnson, Sarah Kennedy, Esther S H Kim, Mary E Maradik, Karlyn A Martin, Eliza C Miller, Susan D Reed, Rachel G Tabak, S Darius Tandon, Rebecca C Thurston, Nisha Verma, Ashley E Weedn, Radhika Rajgopal Singh, Stacey E Rosen","doi":"10.1161/CIR.0000000000001483","DOIUrl":"https://doi.org/10.1161/CIR.0000000000001483","url":null,"abstract":"<p><p>Cardiovascular disease is the leading cause of morbidity and mortality in women, contributes markedly to healthcare expenditures, and is projected to increase substantially by 2050 if current trends continue. There is growing recognition of the complex role of sex as a biologic variable and its influence on cardiovascular health and disease. However, cardiovascular risk remains underrecognized and underaddressed in girls and women, particularly as it relates to female-specific exposure to sex hormones (both endogenous and exogenous), which are systemic modulators of cardiovascular biology. Moreover, girls and women uniquely experience fragmented care spanning specialties, including pediatrics, adolescent medicine, primary care, obstetrics and gynecology, maternal-fetal medicine, cardiology, endocrinology, hematology, and neurology. Consequently, there is a need for a unified life course approach that addresses the female-specific interconnectedness of hormonal, psychosocial, and cardiovascular health. To address these gaps, the American Heart Association, in collaboration with the American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine, established a Female Life Stage framework to optimize the prevention and management of cardiovascular disease in girls and women. Physiologic changes in sex hormones define clinically distinct life stages (ie, perimenarche, ovarian cycling, perimenopause, postmenopause), which directly inform female-specific considerations for screening, prevention, and management of cardiovascular disease. This presidential advisory details the framework and its scientific rationale, highlights opportunities for implementation across settings, and identifies priorities for research, clinician education, patient advocacy, and policy. This framework offers a transformative opportunity to equitably improve cardiovascular health for all girls and women.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study. 左心发育不全综合征的亚型和心室冠状动脉连接的存在:胎儿心脏学会多中心回顾性研究。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.126.080144
David M Barris, Lindsay R Freud, Patrick E Day, Shaine A Morris, Keila N Lopez, Ann Kavanaugh-McHugh, Stacy A S Killen, Shabnam Peyvandi, Flora Nuñez Gallegos, Anita J Moon-Grady, Sanghee Suh Ro, Angela McBrien, Lisa K Hornberger, Caroline K Lee, Whitnee J Hogan, Ron W Reeder, Anjali Chelliah, Lisa W Howley, Bhawna Arya, Sam B Keller, Anita Krishnan, Mary T Donofrio, Carolyn Taylor, Nazia Husain, Bethan A Lemley, Christina Ronai, Sofia Zinis, Wayne Tworetzky, Catherine M Ikemba, Clarelle Gonsalves, Miwa K Geiger, Son Q Duong, Jennifer Cohen
{"title":"Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study.","authors":"David M Barris, Lindsay R Freud, Patrick E Day, Shaine A Morris, Keila N Lopez, Ann Kavanaugh-McHugh, Stacy A S Killen, Shabnam Peyvandi, Flora Nuñez Gallegos, Anita J Moon-Grady, Sanghee Suh Ro, Angela McBrien, Lisa K Hornberger, Caroline K Lee, Whitnee J Hogan, Ron W Reeder, Anjali Chelliah, Lisa W Howley, Bhawna Arya, Sam B Keller, Anita Krishnan, Mary T Donofrio, Carolyn Taylor, Nazia Husain, Bethan A Lemley, Christina Ronai, Sofia Zinis, Wayne Tworetzky, Catherine M Ikemba, Clarelle Gonsalves, Miwa K Geiger, Son Q Duong, Jennifer Cohen","doi":"10.1161/CIRCULATIONAHA.126.080144","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.080144","url":null,"abstract":"<p><strong>Background: </strong>Hypoplastic left heart syndrome (HLHS) is classified by anatomic subtype: mitral atresia and aortic atresia (MA/AA), mitral stenosis and aortic atresia (MS/AA), and mitral stenosis and aortic stenosis (MS/AS). The MS/AA subtype is associated with ventriculocoronary connections (VCCs). We assessed whether specific HLHS subtypes are associated with an increased risk of mortality and whether this risk is stratified by VCCs identified during fetal or postnatal echocardiography. We also assessed whether the type of neonatal intervention performed modified the risk.</p><p><strong>Methods: </strong>We performed a multicenter retrospective cohort study of fetuses and infants <2 months old with HLHS who were admitted between January 2012 and December 2016 to participating Fetal Heart Society institutions. Clinical and demographic data were collected. Fetal and transthoracic echocardiograms from a subset of patients with MS/AA and those with suspected VCCs were reviewed. Cox proportional hazards analysis was performed, controlling for cardiac center (random effect), birth weight, genetic diagnosis, extracardiac malformation, and restricted/intact atrial septum.</p><p><strong>Results: </strong>Among 16 centers, 591 patients were born alive with intention to treat. MA/AA was the most common subtype (261, 44%), followed by MS/AA (200, 34%) and MS/AS (130, 22%). Of those with MS/AA, 115 (58%) had suspected VCCs. Median follow-up was 9.0 (interquartile range: 7.0, 10.8) years. Overall transplant-free survival (TFS) was 55.6% at 5 years and 49.4% at 10 years. When comparing MA/AA, MS/AS, and MS/AA with and without VCCs (reference group: MS/AA without VCCs), MS/AA with VCCs had the lowest TFS (hazard ratio [HR], 1.69 [1.12, 2.57]; 5-year TFS, 44.7%; 10-year TFS, 40.3%). This was followed by MA/AA (HR, 1.40 [0.95, 2.05]; 5-year TFS, 54.1%; 10-year TFS, 46.6%). Survival of MS/AA without VCCs (5-year TFS, 60.4%; 10-year TFS, 56.9%) was similar to MS/AS (HR, 0.91 [0.59, 1.41]; 5-year TFS, 65.0%; 10-year TFS, 58.3%). Among those with a prenatal diagnosis of HLHS (n=532), patients with MS/AA and VCCs suspected on fetal echocardiogram had a lower TFS compared with those with MS/AA without fetal suspicion for VCCs (HR, 1.79 [1.12, 2.85]). Fetal echocardiography was used to diagnose VCCs in 33 of 103 (32%) cases with MS/AA and VCCs suspected postnatally. Of patients with MS/AA and VCCs, type of stage I palliation was not associated with TFS (<i>P</i>=0.784).</p><p><strong>Conclusions: </strong>In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS. Prenatal diagnosis of VCCs was associated with a lower TFS. This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Women's Cardiovascular Health Begins in Childhood. 女性心血管健康始于童年。
IF 41.3 1区 医学
Circulation Pub Date : 2026-10-26 DOI: 10.1161/CIRCULATIONAHA.126.083234
Jessica Y Shim, Amy D DiVasta
{"title":"Women's Cardiovascular Health Begins in Childhood.","authors":"Jessica Y Shim, Amy D DiVasta","doi":"10.1161/CIRCULATIONAHA.126.083234","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.126.083234","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":41.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书